CDX2 and neuroendocrine neoplasm: This case corroborates earlier findings that cytokeratin 7 and pancytokeratin are often positive, while markers such as CDX2 and synaptophysin are negative, helping exclude adenocarcinoma and neuroendocrine tumors, respectively [3,8].